[1]
Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Archives of ophthalmology (Chicago, Ill. : 1960). 1987 Mar:105(3):372-5
[PubMed PMID: 2950846]
[2]
Keltner JL, Thirkill CE, Tyler NK, Roth AM. Management and monitoring of cancer-associated retinopathy. Archives of ophthalmology (Chicago, Ill. : 1960). 1992 Jan:110(1):48-53
[PubMed PMID: 1310001]
[3]
Thirkill CE, FitzGerald P, Sergott RC, Roth AM, Tyler NK, Keltner JL. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. The New England journal of medicine. 1989 Dec 7:321(23):1589-94
[PubMed PMID: 2555714]
[4]
Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: a review and summary. Seminars in immunopathology. 2008 Apr:30(2):127-34. doi: 10.1007/s00281-008-0114-7. Epub 2008 Apr 12
[PubMed PMID: 18408929]
[5]
Dutta Majumder P, Marchese A, Pichi F, Garg I, Agarwal A. An update on autoimmune retinopathy. Indian journal of ophthalmology. 2020 Sep:68(9):1829-1837. doi: 10.4103/ijo.IJO_786_20. Epub
[PubMed PMID: 32823399]
[6]
Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness caused by photoreceptor degeneration as a remote effect of cancer. American journal of ophthalmology. 1976 May:81(5):606-13
[PubMed PMID: 179323]
[7]
Klingele TG, Burde RM, Rappazzo JA, Isserman MJ, Burgess D, Kantor O. Paraneoplastic retinopathy. Journal of clinical neuro-ophthalmology. 1984 Dec:4(4):239-45
[PubMed PMID: 6240497]
[8]
Mizener JB, Kimura AE, Adamus G, Thirkill CE, Goeken JA, Kardon RH. Autoimmune retinopathy in the absence of cancer. American journal of ophthalmology. 1997 May:123(5):607-18
[PubMed PMID: 9152066]
[9]
Henry K. Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment. Seminars in diagnostic pathology. 2019 Jul:36(4):204-210. doi: 10.1053/j.semdp.2019.01.002. Epub 2019 Feb 1
[PubMed PMID: 30876820]
[10]
Naramala S, Ahmad J, Adapa S, Gavini F, Konala VM. Case Series of Cancer-associated Retinopathy (CAR). Cureus. 2019 Jun 10:11(6):e4872. doi: 10.7759/cureus.4872. Epub 2019 Jun 10
[PubMed PMID: 31417817]
Level 2 (mid-level) evidence
[11]
Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration. Possible autoimmune disorder. Archives of ophthalmology (Chicago, Ill. : 1960). 1983 Apr:101(4):564-9
[PubMed PMID: 6838414]
[12]
Katsuta H, Okada M, Nakauchi T, Takahashi Y, Yamao S, Uchida S. Cancer-associated retinopathy associated with invasive thymoma. American journal of ophthalmology. 2002 Sep:134(3):383-9
[PubMed PMID: 12208250]
[13]
Chan JW. Paraneoplastic retinopathies and optic neuropathies. Survey of ophthalmology. 2003 Jan-Feb:48(1):12-38
[PubMed PMID: 12559325]
Level 3 (low-level) evidence
[14]
Dot C, Guigay J, Adamus G. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. American journal of ophthalmology. 2005 Apr:139(4):746-7
[PubMed PMID: 15808190]
[15]
Adamus G. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmunity reviews. 2009 Mar:8(5):410-4. doi: 10.1016/j.autrev.2009.01.002. Epub 2009 Jan 23
[PubMed PMID: 19168157]
[16]
Misiuk-Hojło M, Ejma M, Gorczyca WA, Szymaniec S, Witkowska D, Fortuna W, Miedzybrodzki R, Rogozińska-Szczepka J, Bartnik W. Cancer-associated retinopathy in patients with breast carcinoma. Archivum immunologiae et therapiae experimentalis. 2007 Jul-Aug:55(4):261-5
[PubMed PMID: 17659379]
[17]
Raghunath A, Adamus G, Bodurka DC, Liu J, Schiffman JS. Cancer-associated retinopathy in neuroendocrine carcinoma of the fallopian tube. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2010 Sep:30(3):252-4. doi: 10.1097/WNO.0b013e3181e22ef0. Epub
[PubMed PMID: 20724944]
[18]
Wagley S, Tran TM, Mallory PW, Lee MS, Armbrust KR, Trautman B, Montezuma SR. Cancer-Associated Retinopathy due to Clear Cell Renal Carcinoma. Ocular oncology and pathology. 2021 Mar:7(1):31-35. doi: 10.1159/000511189. Epub 2020 Dec 18
[PubMed PMID: 33796514]
[19]
Matsui Y, Mehta MC, Katsumi O, Brodie SE, Hirose T. Electrophysiological findings in paraneoplastic retinopathy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 1992:230(4):324-8
[PubMed PMID: 1505762]
[20]
Grange L, Dalal M, Nussenblatt RB, Sen HN. Autoimmune retinopathy. American journal of ophthalmology. 2014 Feb:157(2):266-272.e1. doi: 10.1016/j.ajo.2013.09.019. Epub 2013 Sep 29
[PubMed PMID: 24315290]
[21]
Honnorat J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet journal of rare diseases. 2007 May 4:2():22
[PubMed PMID: 17480225]
[22]
Braithwaite T, Vugler A, Tufail A. Autoimmune retinopathy. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde. 2012:228(3):131-42
[PubMed PMID: 22846442]
[23]
Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC ophthalmology. 2004 Jun 4:4():5
[PubMed PMID: 15180904]
[24]
Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2001 Sep:21(3):173-87
[PubMed PMID: 11725182]
Level 3 (low-level) evidence
[25]
Carrera W, Tsamis KA, Shah R. A case of cancer-associated retinopathy with chorioretinitis and optic neuritis associated with occult small cell lung cancer. BMC ophthalmology. 2019 May 2:19(1):101. doi: 10.1186/s12886-019-1103-4. Epub 2019 May 2
[PubMed PMID: 31046716]
Level 3 (low-level) evidence
[26]
Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL. The cancer-associated retinopathy antigen is a recoverin-like protein. Investigative ophthalmology & visual science. 1992 Sep:33(10):2768-72
[PubMed PMID: 1388144]
[27]
Ohguro H, Yokoi Y, Ohguro I, Mamiya K, Ishikawa F, Yamazaki H, Metoki T, Takano Y, Ito T, Nakazawa M. Clinical and immunologic aspects of cancer-associated retinopathy. American journal of ophthalmology. 2004 Jun:137(6):1117-9
[PubMed PMID: 15183799]
[28]
McGinnis JF, Stepanik PL, Baehr W, Subbaraya I, Lerious V. Cloning and sequencing of the 23 kDa mouse photoreceptor cell-specific protein. FEBS letters. 1992 May 11:302(2):172-6
[PubMed PMID: 1386025]
Level 3 (low-level) evidence
[29]
Polans AS, Witkowska D, Haley TL, Amundson D, Baizer L, Adamus G. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proceedings of the National Academy of Sciences of the United States of America. 1995 Sep 26:92(20):9176-80
[PubMed PMID: 7568096]
[30]
Adamus G, Amundson D. Epitope recognition of recoverin in cancer associated retinopathy: evidence for calcium-dependent conformational epitopes. Journal of neuroscience research. 1996 Sep 15:45(6):863-72
[PubMed PMID: 8892098]
[31]
Adamus G, Machnicki M, Seigel GM. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Investigative ophthalmology & visual science. 1997 Feb:38(2):283-91
[PubMed PMID: 9040460]
[32]
Maeda T, Maeda A, Maruyama I, Ogawa KI, Kuroki Y, Sahara H, Sato N, Ohguro H. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Investigative ophthalmology & visual science. 2001 Mar:42(3):705-12
[PubMed PMID: 11222531]
[33]
Cao R, Xue Y, Hedlund EM, Zhong Z, Tritsaris K, Tondelli B, Lucchini F, Zhu Z, Dissing S, Cao Y. VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy. Proceedings of the National Academy of Sciences of the United States of America. 2010 Jan 12:107(2):856-61. doi: 10.1073/pnas.0911661107. Epub 2009 Dec 22
[PubMed PMID: 20080765]
[34]
Suzuki T, Obara Y, Sato Y, Saito G, Ichiwata T, Uchiyama T. Cancer-associated retinopathy with presumed vasculitis. American journal of ophthalmology. 1996 Jul:122(1):125-7
[PubMed PMID: 8659589]
[35]
Shildkrot Y, Sobrin L, Gragoudas ES. Cancer-associated retinopathy: update on pathogenesis and therapy. Seminars in ophthalmology. 2011 Jul-Sep:26(4-5):321-8. doi: 10.3109/08820538.2011.588657. Epub
[PubMed PMID: 21958182]
[36]
Adamus G, Ortega H, Witkowska D, Polans A. Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats. Experimental eye research. 1994 Oct:59(4):447-55
[PubMed PMID: 7859820]
[37]
Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y, Nakazawa M. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation. Investigative ophthalmology & visual science. 2001 Oct:42(11):2589-95
[PubMed PMID: 11581204]
[38]
McGinnis JF, Austin B, Klisak I, Heinzmann C, Kojis T, Sparkes RS, Bateman JB, Lerious V. Chromosomal assignment of the human gene for the cancer-associated retinopathy protein (recoverin) to chromosome 17p13.1. Journal of neuroscience research. 1995 Feb 1:40(2):165-8
[PubMed PMID: 7745609]
[39]
Bazhin AV, De Smet C, Golovastova MO, Schmidt J, Philippov PP. Aberrant demethylation of the recoverin gene is involved in the aberrant expression of recoverin in cancer cells. Experimental dermatology. 2010 Nov:19(11):1023-5. doi: 10.1111/j.1600-0625.2010.01126.x. Epub 2010 Aug 31
[PubMed PMID: 20812967]
[40]
Bazhin AV, Shifrina ON, Savchenko MS, Tikhomirova NK, Goncharskaia MA, Gorbunova VA, Senin II, Chuchalin AG, Philippov PP. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision. Lung cancer (Amsterdam, Netherlands). 2001 Oct:34(1):99-104
[PubMed PMID: 11557119]
[41]
Kobayashi M, Ikezoe T, Uemura Y, Ueno H, Taguchi H. Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy. Lung cancer (Amsterdam, Netherlands). 2007 Sep:57(3):399-403
[PubMed PMID: 17397962]
[42]
Bazhin AV, Savchenko MS, Shifrina ON, Demoura SA, Chikina SY, Jaques G, Kogan EA, Chuchalin AG, Philippov PP. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors. Lung cancer (Amsterdam, Netherlands). 2004 May:44(2):193-8
[PubMed PMID: 15084384]
[43]
Maeda A, Maeda T, Ohguro H, Palczewski K, Sato N. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice. European journal of immunology. 2002 Aug:32(8):2300-7
[PubMed PMID: 12209643]
[44]
Adamus G, Brown L, Weleber RG. Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies. Experimental and molecular pathology. 2009 Dec:87(3):195-203. doi: 10.1016/j.yexmp.2009.08.003. Epub 2009 Sep 8
[PubMed PMID: 19744478]
[45]
Adamus G, Aptsiauri N, Guy J, Heckenlively J, Flannery J, Hargrave PA. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clinical immunology and immunopathology. 1996 Feb:78(2):120-9
[PubMed PMID: 8625554]
[46]
Magrys A, Anekonda T, Ren G, Adamus G. The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. Journal of clinical immunology. 2007 Mar:27(2):181-92
[PubMed PMID: 17235687]
[47]
Grewal DS, Fishman GA, Jampol LM. Autoimmune retinopathy and antiretinal antibodies: a review. Retina (Philadelphia, Pa.). 2014 May:34(5):827-45. doi: 10.1097/IAE.0000000000000119. Epub
[PubMed PMID: 24646664]
[48]
Forooghian F, Adamus G, Sproule M, Westall C, O'Connor P. Enolase autoantibodies and retinal function in multiple sclerosis patients. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2007 Aug:245(8):1077-84
[PubMed PMID: 17219105]
[49]
Terrier B, Degand N, Guilpain P, Servettaz A, Guillevin L, Mouthon L. Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmunity reviews. 2007 Jan:6(3):176-82
[PubMed PMID: 17289554]
[50]
Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, Migliorini P. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. The Journal of rheumatology. 2000 Jan:27(1):109-15
[PubMed PMID: 10648026]
[51]
Ohguro H, Ogawa K, Nakagawa T. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Investigative ophthalmology & visual science. 1999 Jan:40(1):82-9
[PubMed PMID: 9888430]
[52]
Adamus G, Karren L. Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy. Journal of autoimmunity. 2009 Mar:32(2):133-9. doi: 10.1016/j.jaut.2009.02.001. Epub 2009 Mar 6
[PubMed PMID: 19269136]
[53]
Querques G, Thirkill CE, Hagege H, Soubrane G, Souied EH. Choroidal neovascularization associated with cancer-associated retinopathy. Acta ophthalmologica. 2010 Aug:88(5):571-5. doi: 10.1111/j.1755-3768.2008.01456.x. Epub 2008 Dec 24
[PubMed PMID: 19141145]
[54]
Kikuchi T, Arai J, Shibuki H, Kawashima H, Yoshimura N. Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy. Journal of neuroimmunology. 2000 Feb 1:103(1):26-33
[PubMed PMID: 10674986]
[55]
Maeda A, Maeda T, Liang Y, Yenerel M, Saperstein DA. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen. Molecular vision. 2006 Aug 10:12():885-91
[PubMed PMID: 16917481]
[56]
Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunological reviews. 2005 Apr:204():102-15
[PubMed PMID: 15790353]
[57]
Serrano NC, Millan P, Páez MC. Non-HLA associations with autoimmune diseases. Autoimmunity reviews. 2006 Mar:5(3):209-14
[PubMed PMID: 16483921]
[58]
Rizzo JF 3rd, Gittinger JW Jr. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology. 1992 Aug:99(8):1286-95
[PubMed PMID: 1325045]
[59]
Adamus G, Guy J, Schmied JL, Arendt A, Hargrave PA. Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Investigative ophthalmology & visual science. 1993 Aug:34(9):2626-33
[PubMed PMID: 7688357]
[60]
Almeida DR, Chin EK, Niles P, Kardon R, Sohn EH. Unilateral manifestation of autoimmune retinopathy. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2014 Aug:49(4):e85-7. doi: 10.1016/j.jcjo.2014.04.007. Epub 2014 Jul 17
[PubMed PMID: 25103665]
[61]
Ohguro H, Maruyama I, Nakazawa M, Oohira A. Antirecoverin antibody in the aqueous humor of a patient with cancer-associated retinopathy. American journal of ophthalmology. 2002 Oct:134(4):605-7
[PubMed PMID: 12383822]
[62]
Whitcup SM, Vistica BP, Milam AH, Nussenblatt RB, Gery I. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. American journal of ophthalmology. 1998 Aug:126(2):230-7
[PubMed PMID: 9727517]
[63]
Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, Adamus G. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. American journal of ophthalmology. 2005 May:139(5):780-94
[PubMed PMID: 15860281]
[64]
Saito W, Kase S, Ohguro H, Furudate N, Ohno S. Slowly progressive cancer-associated retinopathy. Archives of ophthalmology (Chicago, Ill. : 1960). 2007 Oct:125(10):1431-3
[PubMed PMID: 17923561]
[65]
Jacobson DM, Thirkill CE, Tipping SJ. A clinical triad to diagnose paraneoplastic retinopathy. Annals of neurology. 1990 Aug:28(2):162-7
[PubMed PMID: 2171418]
[66]
Chiang CC, Lin CL, Peng CL, Sung FC, Tsai YY. Increased risk of cancer in patients with early-onset cataracts: a nationwide population-based study. Cancer science. 2014 Apr:105(4):431-6. doi: 10.1111/cas.12360. Epub 2014 Mar 11
[PubMed PMID: 24450445]
[67]
Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicologic pathology. 2010 Jan:38(1):96-109. doi: 10.1177/0192623309356453. Epub 2009 Dec 17
[PubMed PMID: 20019356]
[68]
Michael R, Bron AJ. The ageing lens and cataract: a model of normal and pathological ageing. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2011 Apr 27:366(1568):1278-92. doi: 10.1098/rstb.2010.0300. Epub
[PubMed PMID: 21402586]
[70]
Lima LH, Greenberg JP, Greenstein VC, Smith RT, Sallum JM, Thirkill C, Yannuzzi LA, Tsang SH. Hyperautofluorescent ring in autoimmune retinopathy. Retina (Philadelphia, Pa.). 2012 Jul:32(7):1385-94. doi: 10.1097/IAE.0b013e3182398107. Epub
[PubMed PMID: 22218149]
[71]
Eldred GE, Katz ML. Fluorophores of the human retinal pigment epithelium: separation and spectral characterization. Experimental eye research. 1988 Jul:47(1):71-86
[PubMed PMID: 3409988]
[72]
von Rückmann A, Fitzke FW, Bird AC. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. The British journal of ophthalmology. 1995 May:79(5):407-12
[PubMed PMID: 7612549]
[73]
Kennedy CJ, Rakoczy PE, Constable IJ. Lipofuscin of the retinal pigment epithelium: a review. Eye (London, England). 1995:9 ( Pt 6)():763-71
[PubMed PMID: 8849547]
[74]
Aguirre-Lamban J, Riveiro-Alvarez R, Maia-Lopes S, Cantalapiedra D, Vallespin E, Avila-Fernandez A, Villaverde-Montero C, Trujillo-Tiebas MJ, Ramos C, Ayuso C. Molecular analysis of the ABCA4 gene for reliable detection of allelic variations in Spanish patients: identification of 21 novel variants. The British journal of ophthalmology. 2009 May:93(5):614-21. doi: 10.1136/bjo.2008.145193. Epub 2008 Nov 21
[PubMed PMID: 19028736]
[75]
Tsang SH, Vaclavik V, Bird AC, Robson AG, Holder GE. Novel phenotypic and genotypic findings in X-linked retinoschisis. Archives of ophthalmology (Chicago, Ill. : 1960). 2007 Feb:125(2):259-67
[PubMed PMID: 17296904]
[76]
Scholl HP, Chong NH, Robson AG, Holder GE, Moore AT, Bird AC. Fundus autofluorescence in patients with leber congenital amaurosis. Investigative ophthalmology & visual science. 2004 Aug:45(8):2747-52
[PubMed PMID: 15277500]
[77]
Pichi F, Abboud EB, Ghazi NG, Khan AO. Fundus autofluorescence imaging in hereditary retinal diseases. Acta ophthalmologica. 2018 Aug:96(5):e549-e561. doi: 10.1111/aos.13602. Epub 2017 Nov 2
[PubMed PMID: 29098804]
[78]
Murakami T, Akimoto M, Ooto S, Suzuki T, Ikeda H, Kawagoe N, Takahashi M, Yoshimura N. Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa. American journal of ophthalmology. 2008 Apr:145(4):687-94. doi: 10.1016/j.ajo.2007.11.018. Epub 2008 Feb 1
[PubMed PMID: 18242574]
[80]
Pepple KL, Cusick M, Jaffe GJ, Mruthyunjaya P. SD-OCT and autofluorescence characteristics of autoimmune retinopathy. The British journal of ophthalmology. 2013 Feb:97(2):139-44. doi: 10.1136/bjophthalmol-2012-302524. Epub 2012 Dec 5
[PubMed PMID: 23221966]
[81]
Abazari A, Allam SS, Adamus G, Ghazi NG. Optical coherence tomography findings in autoimmune retinopathy. American journal of ophthalmology. 2012 Apr:153(4):750-6, 756.e1. doi: 10.1016/j.ajo.2011.09.012. Epub 2012 Jan 14
[PubMed PMID: 22245461]
[82]
Sepah YJ, Sadiq MA, Hassan M, Hanout M, Soliman M, Agarwal A, Afridi R, Coupland SG, Nguyen QD. Assessment of Retinal Structural and Functional Characteristics in Eyes with Autoimmune Retinopathy. Current molecular medicine. 2015:15(6):578-86
[PubMed PMID: 26238366]
[83]
Khanna S, Martins A, Oakey Z, Mititelu M. Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases. Journal of ophthalmic inflammation and infection. 2019 Feb 26:9(1):6. doi: 10.1186/s12348-019-0171-1. Epub 2019 Feb 26
[PubMed PMID: 30806850]
Level 3 (low-level) evidence
[84]
Finn AP, Thomas AS, Stinnett SS, Keenan RT, Grewal DS, Jaffe GJ. The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2018 Oct:256(10):1867-1873. doi: 10.1007/s00417-018-4084-8. Epub 2018 Aug 20
[PubMed PMID: 30128606]
[85]
Igarashi N, Sawamura H, Kaburaki T, Aihara M. Cancer-associated Retinopathy Developing After 10 Years of Complete Breast Cancer Remission. Neuro-ophthalmology (Aeolus Press). 2019 Feb:43(1):36-42. doi: 10.1080/01658107.2018.1460761. Epub 2018 May 23
[PubMed PMID: 30723523]
[86]
Neena R, Jain A, Anantharaman G, Antony MA. Carcinoma -associated Retinopathy(CAR): Role of Electroretinography(ERG) and Optical coherence Tomography(OCT) in diagnosis and predicting treatment outcome. American journal of ophthalmology case reports. 2021 Mar:21():101008. doi: 10.1016/j.ajoc.2020.101008. Epub 2021 Jan 13
[PubMed PMID: 33511304]
Level 3 (low-level) evidence
[88]
Wachtmeister L. Oscillatory potentials in the retina: what do they reveal. Progress in retinal and eye research. 1998 Oct:17(4):485-521
[PubMed PMID: 9777648]
[89]
Link B, Schlötzer-Schrehardt U, Jünemann A. Carcinoma-associated retinopathy-an electrophysiological and immunohistochemical correlation. Retina (Philadelphia, Pa.). 2009 Jan:29(1):69-72. doi: 10.1097/IAE.0b013e3181853d06. Epub
[PubMed PMID: 18728619]
[90]
Goetgebuer G, Kestelyn-Stevens AM, De Laey JJ, Kestelyn P, Leroy BP. Cancer-associated retinopathy (CAR) with electronegative ERG: a case report. Documenta ophthalmologica. Advances in ophthalmology. 2008 Jan:116(1):49-55
[PubMed PMID: 17721792]
Level 3 (low-level) evidence
[91]
Mohamed Q, Harper CA. Acute optical coherence tomographic findings in cancer-associated retinopathy. Archives of ophthalmology (Chicago, Ill. : 1960). 2007 Aug:125(8):1132-3
[PubMed PMID: 17698766]
[92]
Kornguth SE, Klein R, Appen R, Choate J. Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer. 1982 Oct 1:50(7):1289-93
[PubMed PMID: 6286090]
[93]
Ko AC, Brinton JP, Mahajan VB, Zimmerman B, Brinton GS, Stone EM, Folk JC, Mullins RF. Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis. Archives of ophthalmology (Chicago, Ill. : 1960). 2011 Apr:129(4):415-20. doi: 10.1001/archophthalmol.2011.65. Epub
[PubMed PMID: 21482867]
[94]
Forooghian F, Cao S, Cui J, Matsubara JA. The enigma of autoimmune retinopathy. International ophthalmology clinics. 2015 Spring:55(2):81-91. doi: 10.1097/IIO.0000000000000063. Epub
[PubMed PMID: 25730621]
[95]
Murphy MA, Thirkill CE, Hart WM Jr. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 1997 Jun:17(2):77-83
[PubMed PMID: 9176775]
[96]
Huynh N, Shildkrot Y, Lobo AM, Sobrin L. Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy. Journal of ophthalmic inflammation and infection. 2012 Sep:2(3):169-71. doi: 10.1007/s12348-012-0067-9. Epub 2012 Mar 14
[PubMed PMID: 22415770]
[97]
Javaid Z, Rehan SM, Al-Bermani A, Payne G. Unilateral cancer-associated retinopathy: a case report. Scottish medical journal. 2016 Aug:61(3):155-159
[PubMed PMID: 26246524]
Level 3 (low-level) evidence
[98]
Ferreyra HA, Jayasundera T, Khan NW, He S, Lu Y, Heckenlively JR. Management of autoimmune retinopathies with immunosuppression. Archives of ophthalmology (Chicago, Ill. : 1960). 2009 Apr:127(4):390-7. doi: 10.1001/archophthalmol.2009.24. Epub
[PubMed PMID: 19365013]
[99]
Jacobzone C, Cochard-Marianowski C, Kupfer I, Bettembourg S, Dordain Y, Misery L, Cochener B, Sassolas B. Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings. Archives of dermatology. 2004 Oct:140(10):1258-61
[PubMed PMID: 15492190]
[100]
Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Archives of ophthalmology (Chicago, Ill. : 1960). 1999 Apr:117(4):471-7
[PubMed PMID: 10206574]
Level 3 (low-level) evidence
[101]
Mahdi N, Faia LJ, Goodwin J, Nussenblatt RB, Sen HN. A case of autoimmune retinopathy associated with thyroid carcinoma. Ocular immunology and inflammation. 2010 Aug:18(4):322-3. doi: 10.3109/09273941003802379. Epub
[PubMed PMID: 20662664]
Level 3 (low-level) evidence
[102]
Davoudi S, Ebrahimiadib N, Yasa C, Sevgi DD, Roohipoor R, Papavasilieou E, Comander J, Sobrin L. Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab. American journal of ophthalmology. 2017 Aug:180():124-132. doi: 10.1016/j.ajo.2017.04.019. Epub 2017 May 5
[PubMed PMID: 28483493]
[103]
Adamus G, Machnicki M, Elerding H, Sugden B, Blocker YS, Fox DA. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. Journal of autoimmunity. 1998 Oct:11(5):523-33
[PubMed PMID: 9802939]
[104]
Adamus G, Webb S, Shiraga S, Duvoisin RM. Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. Journal of autoimmunity. 2006 Mar:26(2):146-53
[PubMed PMID: 16426815]
[105]
Adamus G, Sugden B, Shiraga S, Timmers AM, Hauswirth WW. Anti-apoptotic effects of CNTF gene transfer on photoreceptor degeneration in experimental antibody-induced retinopathy. Journal of autoimmunity. 2003 Sep:21(2):121-9
[PubMed PMID: 12935781]
[106]
Fishman GA. Retinitis pigmentosa. Visual loss. Archives of ophthalmology (Chicago, Ill. : 1960). 1978 Jul:96(7):1185-8
[PubMed PMID: 307377]
[107]
Fishman GA, Farber MD, Derlacki DJ. X-linked retinitis pigmentosa. Profile of clinical findings. Archives of ophthalmology (Chicago, Ill. : 1960). 1988 Mar:106(3):369-75
[PubMed PMID: 3257866]
[108]
Heckenlively JR, Aptsiauri N, Nusinowitz S, Peng C, Hargrave PA. Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations. Transactions of the American Ophthalmological Society. 1996:94():179-200; discussion 200-6
[PubMed PMID: 8981696]
[109]
Takeuchi M, Usui Y, Okunuki Y, Zhang L, Ma J, Yamakawa N, Hattori T, Kezuka T, Sakai J, Goto H. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis. Investigative ophthalmology & visual science. 2010 Jun:51(6):3067-75. doi: 10.1167/iovs.09-4313. Epub 2010 Jan 20
[PubMed PMID: 20089879]
[110]
Naik A, Ratra D, Banerjee A, Dalan D, Jandyal S, Rao G, Sen P, Bhende M, Jayaprakash V, Susvar P, Walinjkar J, Rao C. Enhanced S-cone syndrome: Clinical spectrum in Indian population. Indian journal of ophthalmology. 2019 Apr:67(4):523-529. doi: 10.4103/ijo.IJO_1480_18. Epub
[PubMed PMID: 30900587]
[111]
Tripathy K, Sharma YR, Chawla R, Basu K, Vohra R, Venkatesh P. Triads in Ophthalmology: A Comprehensive Review. Seminars in ophthalmology. 2017:32(2):237-250. doi: 10.3109/08820538.2015.1045150. Epub 2015 Jul 6
[PubMed PMID: 26148300]
[112]
Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet (London, England). 2006 Nov 18:368(9549):1795-809
[PubMed PMID: 17113430]
[113]
Heckenlively JR, Fawzi AA, Oversier J, Jordan BL, Aptsiauri N. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Archives of ophthalmology (Chicago, Ill. : 1960). 2000 Nov:118(11):1525-33
[PubMed PMID: 11074809]
[114]
Nieuwendijk TJ, Hooymans JM. Paraneoplastic vitelliform retinopathy associated with metastatic choroidal melanoma. Eye (London, England). 2007 Nov:21(11):1436-7
[PubMed PMID: 17693995]
[115]
Elsheikh S, Gurney SP, Burdon MA. Melanoma-associated retinopathy. Clinical and experimental dermatology. 2020 Mar:45(2):147-152. doi: 10.1111/ced.14095. Epub 2019 Nov 19
[PubMed PMID: 31742740]
[116]
Janáky M, Pálffy A, Kolozsvári L, Benedek G. Unilateral manifestation of melanoma-associated retinopathy. Archives of ophthalmology (Chicago, Ill. : 1960). 2002 Jun:120(6):866-7
[PubMed PMID: 12049605]
[117]
Fujiwara T, Imamura Y, Giovinazzo VJ, Spaide RF. Fundus autofluorescence and optical coherence tomographic findings in acute zonal occult outer retinopathy. Retina (Philadelphia, Pa.). 2010 Sep:30(8):1206-16. doi: 10.1097/IAE.0b013e3181e097f0. Epub
[PubMed PMID: 20661173]
[118]
Yeh S, Forooghian F, Wong WT, Faia LJ, Cukras C, Lew JC, Wroblewski K, Weichel ED, Meyerle CB, Sen HN, Chew EY, Nussenblatt RB. Fundus autofluorescence imaging of the white dot syndromes. Archives of ophthalmology (Chicago, Ill. : 1960). 2010 Jan:128(1):46-56. doi: 10.1001/archophthalmol.2009.368. Epub
[PubMed PMID: 20065216]
[120]
Iijima H, Yamaguchi S, Kogure S, Hosaka O, Shibutani T. Electroretinogram in cone dystrophy. Japanese journal of ophthalmology. 1991:35(4):453-66
[PubMed PMID: 1821435]
[121]
Sharma P, Sharma R. Toxic optic neuropathy. Indian journal of ophthalmology. 2011 Mar-Apr:59(2):137-41. doi: 10.4103/0301-4738.77035. Epub
[PubMed PMID: 21350283]
[123]
Sajjadi H, Poorsalman H. Previously Diagnosed Leber's Hereditary Optic Neuropathy with Clinical Signs of Idiopathic Intracranial Hypertension Responsive to Acetazolamide Therapy. Journal of ophthalmic & vision research. 2019 Jan-Mar:14(1):109-113. doi: 10.4103/jovr.jovr_85_18. Epub
[PubMed PMID: 30820297]
[124]
Mauri E, Dilena R, Boccazzi A, Ronchi D, Piga D, Triulzi F, Gagliardi D, Brusa R, Faravelli I, Bresolin N, Magri F, Corti S, Comi GP. Subclinical Leber's hereditary optic neuropathy with pediatric acute spinal cord onset: more than meets the eye. BMC neurology. 2018 Dec 27:18(1):220. doi: 10.1186/s12883-018-1227-9. Epub 2018 Dec 27
[PubMed PMID: 30591017]
[125]
Glover JM, Casmaer ML, April MD. An uncommon cause of vision loss: Leber hereditary optic neuropathy. JAAPA : official journal of the American Academy of Physician Assistants. 2018 Nov:31(11):32-34. doi: 10.1097/01.JAA.0000546478.56818.50. Epub
[PubMed PMID: 30358677]
[126]
Savini G, Barboni P, Valentino ML, Montagna P, Cortelli P, De Negri AM, Sadun F, Bianchi S, Longanesi L, Zanini M, Carelli V. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology. 2005 Jan:112(1):127-31
[PubMed PMID: 15629832]
[127]
Quiros PA, Torres RJ, Salomao S, Berezovsky A, Carelli V, Sherman J, Sadun F, De Negri A, Belfort R, Sadun AA. Colour vision defects in asymptomatic carriers of the Leber's hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study. The British journal of ophthalmology. 2006 Feb:90(2):150-3
[PubMed PMID: 16424523]
Level 2 (mid-level) evidence
[128]
Sadun AA, Salomao SR, Berezovsky A, Sadun F, Denegri AM, Quiros PA, Chicani F, Ventura D, Barboni P, Sherman J, Sutter E, Belfort R Jr, Carelli V. Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study. Transactions of the American Ophthalmological Society. 2006:104():51-61
[PubMed PMID: 17471325]
[129]
Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. Journal of medical genetics. 2009 Mar:46(3):145-58. doi: 10.1136/jmg.2007.054270. Epub 2008 Nov 10
[PubMed PMID: 19001017]
[130]
Riordan-Eva P, Harding AE. Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations. Journal of medical genetics. 1995 Feb:32(2):81-7
[PubMed PMID: 7760326]
[131]
Machemer R. [On the pathogenesis of the flat malignant melanoma]. Klinische Monatsblatter fur Augenheilkunde. 1966:148(5):641-52
[PubMed PMID: 5996537]
[132]
Barr CC, Zimmerman LE, Curtin VT, Font RL. Bilateral diffuse melanocytic uveal tumors associated with systemic malignant neoplasms. A recently recognized syndrome. Archives of ophthalmology (Chicago, Ill. : 1960). 1982 Feb:100(2):249-55
[PubMed PMID: 7065942]
[133]
van Noort BC, Keunen JEE, Schlingemann RO, Marinkovic M. Long Survival and Preservation of Good Visual Acuity in a Patient with Bilateral Diffuse Uveal Melanocytic Proliferation. Ocular oncology and pathology. 2019 Jan:5(1):75-78. doi: 10.1159/000488454. Epub 2018 Jun 19
[PubMed PMID: 30675481]
[134]
Klemp K, Kiilgaard JF, Heegaard S, Nørgaard T, Andersen MK, Prause JU. Bilateral diffuse uveal melanocytic proliferation: Case report and literature review. Acta ophthalmologica. 2017 Aug:95(5):439-445. doi: 10.1111/aos.13481. Epub 2017 Jun 21
[PubMed PMID: 28636126]
Level 3 (low-level) evidence
[135]
Gass JD, Gieser RG, Wilkinson CP, Beahm DE, Pautler SE. Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma. Archives of ophthalmology (Chicago, Ill. : 1960). 1990 Apr:108(4):527-33
[PubMed PMID: 2322154]
[136]
Rahimy E, Soheilian M. Giraffe Pattern of Bilateral Diffuse Uveal Melanocytic Proliferation. Ophthalmology. 2016 Mar:123(3):483. doi: 10.1016/j.ophtha.2015.12.015. Epub
[PubMed PMID: 26902560]
[137]
Chahud F, Young RH, Remulla JF, Khadem JJ, Dryja TP. Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers: review of a process particularly associated with gynecologic cancers. The American journal of surgical pathology. 2001 Feb:25(2):212-8
[PubMed PMID: 11176070]
[138]
Liu B, Deng T, Zhang J. RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis. Retina (Philadelphia, Pa.). 2016 Jan:36(1):9-19. doi: 10.1097/IAE.0000000000000837. Epub
[PubMed PMID: 26710181]
Level 1 (high-level) evidence
[139]
Gäckle HC, Lang GE, Freissler KA, Lang GK. [Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 1998 Aug:95(8):529-33
[PubMed PMID: 9782727]
[140]
Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL, Freund B, Guyer DR, Slakter JS, Sorenson JA. Systemic findings associated with central serous chorioretinopathy. American journal of ophthalmology. 1999 Jul:128(1):63-8
[PubMed PMID: 10482095]
Level 3 (low-level) evidence
[141]
Yalcinbayir O, Gelisken O, Akova-Budak B, Ozkaya G, Gorkem Cevik S, Yucel AA. Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy. Retina (Philadelphia, Pa.). 2014 Apr:34(4):705-12. doi: 10.1097/IAE.0000000000000001. Epub
[PubMed PMID: 24100708]
[143]
Xu Q, Du W, Zhou H, Zhang X, Liu H, Song H, Wang X, Wei S. Distinct clinical characteristics of paraneoplastic optic neuropathy. The British journal of ophthalmology. 2019 Jun:103(6):797-801. doi: 10.1136/bjophthalmol-2018-312046. Epub 2018 Jul 18
[PubMed PMID: 30021813]
[144]
Malik S, Furlan AJ, Sweeney PJ, Kosmorsky GS, Wong M. Optic neuropathy: a rare paraneoplastic syndrome. Journal of clinical neuro-ophthalmology. 1992 Sep:12(3):137-41
[PubMed PMID: 1328306]
[145]
Paul R, Ghosh AK, Sinha A, Bhattacharya R. Paraneoplastic optic neuritis as the first manifestation of periampullary carcinoma. International journal of applied & basic medical research. 2015 Jan-Apr:5(1):73-5. doi: 10.4103/2229-516X.149255. Epub
[PubMed PMID: 25664276]
[146]
Rosencher L, Maisonobe T, Lavole A, Milleron B, Ferroir JP. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment]. Revue neurologique. 2012 Apr:168(4):371-4. doi: 10.1016/j.neurol.2011.07.016. Epub 2012 Mar 3
[PubMed PMID: 22387203]
[147]
Langer JE, Lopes MB, Fountain NB, Pranzatelli MR, Thiele EA, Rust RS, Goodkin HP. An unusual presentation of anti-Hu-associated paraneoplastic limbic encephalitis. Developmental medicine and child neurology. 2012 Sep:54(9):863-6. doi: 10.1111/j.1469-8749.2012.04221.x. Epub 2012 Feb 9
[PubMed PMID: 22320677]
[148]
Damek DM. Paraneoplastic Retinopathy/Optic Neuropathy. Current treatment options in neurology. 2005 Jan:7(1):57-67
[PubMed PMID: 15610708]
[149]
Wiseman EM, Bar-El Dadon S, Reifen R. The vicious cycle of vitamin a deficiency: A review. Critical reviews in food science and nutrition. 2017 Nov 22:57(17):3703-3714. doi: 10.1080/10408398.2016.1160362. Epub
[PubMed PMID: 27128154]
[150]
D'Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: an update. Nutrients. 2011 Jan:3(1):63-103. doi: 10.3390/nu3010063. Epub
[PubMed PMID: 21350678]
[151]
Pfeiffer CM, Sternberg MR, Schleicher RL, Haynes BM, Rybak ME, Pirkle JL. The CDC's Second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population is a valuable tool for researchers and policy makers. The Journal of nutrition. 2013 Jun:143(6):938S-47S. doi: 10.3945/jn.112.172858. Epub 2013 Apr 17
[PubMed PMID: 23596164]
[153]
Miller M, Humphrey J, Johnson E, Marinda E, Brookmeyer R, Katz J. Why do children become vitamin A deficient? The Journal of nutrition. 2002 Sep:132(9 Suppl):2867S-2880S. doi: 10.1093/jn/132.9.2867S. Epub
[PubMed PMID: 12221263]
[154]
McBain VA, Egan CA, Pieris SJ, Supramaniam G, Webster AR, Bird AC, Holder GE. Functional observations in vitamin A deficiency: diagnosis and time course of recovery. Eye (London, England). 2007 Mar:21(3):367-76
[PubMed PMID: 16341129]
[155]
Aleman TS, Garrity ST, Brucker AJ. Retinal structure in vitamin A deficiency as explored with multimodal imaging. Documenta ophthalmologica. Advances in ophthalmology. 2013 Dec:127(3):239-43. doi: 10.1007/s10633-013-9403-0. Epub 2013 Jul 31
[PubMed PMID: 23900584]
Level 3 (low-level) evidence
[157]
Goldstein SM, Syed NA, Milam AH, Maguire AM, Lawton TJ, Nichols CW. Cancer-associated retinopathy. Archives of ophthalmology (Chicago, Ill. : 1960). 1999 Dec:117(12):1641-5
[PubMed PMID: 10604671]
[158]
Adamus G, Brown L, Schiffman J, Iannaccone A. Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy. Journal of ophthalmic inflammation and infection. 2011 Sep:1(3):111-21. doi: 10.1007/s12348-011-0028-8. Epub 2011 Jul 10
[PubMed PMID: 21744285]